Drug intelligence / Profile preview

Ziziphus nummularia stem ethanol extract

Development stage: Preclinical
Administration: Oral, Topical

Overview

This extract is derived from the stem of *Ziziphus nummularia*, a plant traditionally used in folk medicine. It has been studied for its potential anticancer properties, particularly in inhibiting cancer cell proliferation. The extract contains various bioactive compounds, including flavonoids and phenols, which contribute to its biological activities such as antioxidant and antibacterial effects.

Other names: Ziziphus nummularia ethanol extract from stem

Targets

TP53RK (TP53 regulating kinase)TP53 (Cellular Tumor Antigen p53 R175H)TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on Ziziphus nummularia stem ethanol extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ziziphus nummularia stem ethanol extract.

Explore the full profile